facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
5/2020
vol. 107
 
Share:
Share:
abstract:
Case report

Therapeutic difficulties related to optimization of pemphigus vulgaris treatment

Szymon Leonik
1
,
Emilia Karpińska
1
,
Agnieszka Owsińska
1
,
Katarzyna Sedlaczek
1
,
Beata Bergler-Czop
2

  1. Student Scientific Society at the Department of Dermatology, Medical University of Silesia, Katowice, Poland
  2. Department of Dermatology, Medical University of Silesia, Katowice, Poland
Dermatol Rev/Przegl Dermatol 2020, 107, 459-464
Online publish date: 2020/12/29
View full text Get citation
 
PlumX metrics:
A 60-year-old man with extensive erosive lesions within the scalp and face, limbs, trunk, and nasal and oral mucous membrane involvement was admitted to the ward with worsening of symptoms in the course of pemphigus vulgaris. The exacerbation took place during an attempt to reduce doses of immunosuppressive drugs and glucocorticosteroids. Additional examinations, otorhinolaryngological and dental consultation did not show another cause of this condition. Biological therapy with a monoclonal antibody directed against the CD20 antigen, rituximab, was introduced. The study presents the treatment efficacy in the patient 2 weeks after the last drug dose and compares them with the latest available knowledge on rituximab therapy in pemphigus vulgaris.
keywords:

rituximab, pemphigus vulgaris, bullous diseases



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.